We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Clover Health Investments
CLOV
$2.51B
| $327K | 0.03% |
386,365
+311,714
| +418% | +$341K |
|
977
HubSpot
HUBS
$10.5B
| $327K | 0.03% |
762
-1,899
| -71% | -$693K |
|
978
Alight
ALIT
$407M
| $326K | 0.03% |
+1,770
| New | +$325K |
|
979
BlueLinx
BXC
$706M
| $326K | 0.03% |
+4,803
| New | +$389K |
|
980
Scholastic
SCHL
$792M
| $326K | 0.03% |
9,536
+3,614
| +61% | +$154K |
|
981
Energy Recovery
ERII
$443M
| $325K | 0.03% |
+14,101
| New | +$310K |
|
982
SandRidge Energy
SD
$503M
| $325K | 0.03% |
22,543
+12,245
| +119% | +$187K |
|
983
Wabtec
WAB
$49.3B
| $325K | 0.03% |
+3,215
| New | +$328K |
|
984
Advanced Micro Devices
AMD
$789B
| $324K | 0.03% |
+3,305
| New | +$269K |
|
985
DMC Global
BOOM
$157M
| $324K | 0.03% |
14,729
-4,193
| -22% | -$96K |
|
986
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $324K | 0.03% |
+30,135
| New | +$397K |
|
|
INFN
987
DELISTED
Infinera Corporation Common Stock
INFN
| $322K | 0.03% |
41,513
-109,871
| -73% | -$799K |
|
988
Chesapeake Utilities
CPK
$3.21B
| $321K | 0.03% |
+2,505
| New | +$311K |
|
989
LSB Industries
LXU
$693M
| $321K | 0.03% |
+31,084
| New | +$379K |
|
990
Thermo Fisher Scientific
TMO
$220B
| $321K | 0.03% |
+557
| New | +$314K |
|
991
VanEck Retail ETF
RTH
$263M
| $320K | 0.03% |
+1,955
| New | +$317K |
|
|
CIM
992
Chimera Investment
CIM
$1B
| $319K | 0.03% |
+18,872
| New | +$361K |
|
993
Plexus
PLXS
$7.23B
| $319K | 0.03% |
3,267
-4,315
| -57% | -$433K |
|
994
TFS Financial
TFSL
$4.93B
| $319K | 0.03% |
+25,271
| New | +$353K |
|
995
iShares MSCI USA Value Factor ETF
VLUE
$9.47B
| $318K | 0.03% |
+3,438
| New | +$324K |
|
|
AHRT
996
AH Realty Trust
AHRT
$517M
| $316K | 0.03% |
26,726
-45,418
| -63% | -$558K |
|
997
General Dynamics
GD
$106B
| $314K | 0.03% |
1,377
-169
| -11% | -$39K |
|
998
Financial Institutions
FISI
$821M
| $313K | 0.03% |
+16,226
| New | +$380K |
|
|
MITT
999
TPG Mortgage Investment Trust
MITT
$225M
| $313K | 0.03% |
+54,378
| New | +$329K |
|
1000
Public Storage
PSA
$61.3B
| $313K | 0.03% |
1,036
-779
| -43% | -$229K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.